ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

PDSB PDS Biotechnology Corporation

2.74
0.00 (0.00%)
2024年6月20日 - 終了
15分遅延
名称 銘柄コード 市場 種別
PDS Biotechnology Corporation PDSB NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.00 0.00% 2.74 09:00:00
始値 安値 高値 終値 前日終値
2.74
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/6/1221:05EDGAR2Form 8-K - Current report
2024/5/1606:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/1521:00EDGAR2Form 8-K - Current report
2024/5/0905:05EDGAR2Form 8-K - Current report
2024/1/2406:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2406:31EDGAR2Form 3 - Initial statement of beneficial ownership of..
2024/1/2307:10EDGAR2Form 8-K - Current report
2024/1/2306:45GLOBEPDS Biotech Announces Retirement of Lauren V. Wood, M.D.,..
2024/1/1622:00GLOBEPDS Biotech to Participate at B. Riley Securities 4th Annual..
2023/12/0506:50GLOBEPDS Biotechnology Reports Inducement Grant Under Nasdaq..
2023/12/0506:02EDGAR2Form 8-K - Current report
2023/11/2821:30GLOBEPDS Biotech Appoints Lars Boesgaard as Chief Financial..
2023/11/2820:02EDGAR2Form 8-K - Current report
2023/11/1421:30GLOBEPDS Biotech Reports Third Quarter 2023 Financial Results and..
2023/11/1006:07EDGAR2Form 8-K - Current report
2023/11/0922:00GLOBEPDS Biotech Announces Updated Survival Data from NCI-Led..
2023/11/0722:00GLOBEPDS Biotechnology Announces Conference Call and Webcast for..
2023/10/2405:06EDGAR2Form 8-K - Current report
2023/10/2321:00GLOBEPDS Biotech Announces Preliminary Biomarker Study Results in..
2023/10/1205:02EDGAR2Form 8-K - Current report
2023/10/1121:00GLOBEPDS Biotech Announces Interim Safety and Immune Response..
2023/10/0405:03EDGAR2Form 8-K - Current report
2023/10/0405:03EDGAR2Form 8-K - Current report
2023/10/0322:02EDGAR2Form 8-K - Current report
2023/10/0320:00GLOBEPDS Biotech Announces Interim 24-Month Survival Rate of 74%..
2023/10/0305:05EDGAR2Form 8-K - Current report
2023/10/0221:00GLOBEPDS Biotech Announces PDS0101 Combined with..
2023/9/2621:00GLOBEPDS Biotech to Present at the LD Micro Main Event XVI
2023/9/2521:00GLOBEPDS Biotech Reschedules Key Opinion Leader Roundtable..
2023/9/2105:10EDGAR2Form 8-K - Current report
2023/9/2105:05GLOBEPDS Biotech to Participate in the 2023 Cantor Fitzgerald..
2023/9/2021:00GLOBEPDS Biotech Announces PDS0202 Elicits Active Neutralization..
2023/9/1321:00GLOBEPDS Biotech to Host Key Opinion Leader Roundtable Addressing..
2023/9/1205:05EDGAR2Form 8-K - Current report
2023/9/0819:02EDGAR2Form 8-K - Current report
2023/9/0705:05GLOBEPDS Biotech to Participate at the H.C. Wainwright 25th..
2023/9/0621:00GLOBEPDS0202 Universal Influenza Preclinical Ferret Data to be..
2023/8/1905:04EDGAR2Form 8-K - Current report
2023/8/1805:05EDGAR2Form 8-K - Current report
2023/8/1621:00GLOBEPDS Biotech Announces Data from IMMUNOCERV Phase 2 Trial..
2023/8/1505:05EDGAR2Form 8-K - Current report
2023/8/1502:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/1420:30GLOBEPDS Biotech Reports Second Quarter 2023 Financial Results..
2023/8/1420:00GLOBEPDS Biotech Announces Submission of Phase 3 Protocol to FDA..
2023/8/0721:00GLOBEPDS Biotechnology Announces Conference Call and Webcast for..
2023/8/0221:00GLOBEPDS Biotech to Present at BTIG Virtual Biotechnology..
2023/7/2605:01EDGAR2Form 8-K - Current report
2023/7/2521:00GLOBEPDS Biotech to Present Immune Response Data from Combination..
2023/7/1806:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/1806:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..

最近閲覧した銘柄

Delayed Upgrade Clock